Démarche diagnostique dans les lymphomes : Lymphomes de l'adulte = Diagnosis of lymphomas : Lymphomas in the adultTILLY, Hervé.La Revue du praticien (Paris). 2002, Vol 52, Num 9, pp 959-965, issn 0035-2640Article

Un saut (de puce) vers une application clinique des profils d'expression génique dans les lymphomes = Clinical application of gene-expression profiling in lymphomeJARDIN, Fabrice; TILLY, Hervé.MS. Médecine sciences. 2004, Vol 20, Num 10, pp 848-850, issn 0767-0974, 3 p.Article

Lymphomes non hodgkiniensJARDIN, Fabrice; TILLY, Hervé.Hématologie (Montrouge). 2006, Vol 12, pp 17-24, issn 1264-7527, 8 p., NS2Conference Paper

The BCL6 proto-oncogene : a leading role during germinal center development and lymphomagenesisJARDIN, Fabrice; RUMINY, Philippe; BASTARD, Christian et al.Pathologie et biologie. 2007, Vol 55, Num 1, pp 73-83, issn 0369-8114, 11 p.Article

Mutations somatiques du gène BCL-6 et oncogenèse des lymphomes B = Somatic mutations of the BCL-6 gene and B-cell lymphoma oncogenesisJARDIN, Fabrice; RUMINY, Philippe; PARMENTIER, Francoise et al.Hématologie (Montrouge). 2004, Vol 10, Num 1, pp 47-58, issn 1264-7527, 12 p.Article

Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-hodgkin lymphoma: Relationship with tumor aggressivenessBERTRAND, Philippe; COUREL, Marie-Noëlle; MAINGONNAT, Catherine et al.International journal of cancer. 2005, Vol 113, Num 2, pp 207-212, issn 0020-7136, 6 p.Article

Human monocytes synthesize hyaluronidaseGIRARD, Nicole; MAINGONNAT, Catherine; BERTRAND, Philippe et al.British journal of haematology. 2002, Vol 119, Num 1, pp 199-203, issn 0007-1048Article

Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years oldITALIANO, Antoine; JARDIN, Fabrics; PEYRADE, Frederic et al.Haematologica (Roma). 2005, Vol 90, Num 9, pp 1281-1283, issn 0390-6078, 3 p.Article

Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With ImmunochemotherapyMAURER, Matthew J; GHESQUIERES, Hervé; MOLINA, Thierry Jo et al.Journal of clinical oncology. 2014, Vol 32, Num 10, pp 1066-1073, issn 0732-183X, 8 p.Article

Therapeutic options in relapsed or refractory peripheral T-cell lymphomaCOIFFIER, Bertrand; FEDERICO, Massimo; WEIDMANN, Eckhart et al.Cancer treatment reviews. 2014, Vol 40, Num 9, pp 1080-1088, issn 0305-7372, 9 p.Article

Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patientsLEFRERE, François; BASTIT-BARRAU, Dominique; FORNECKER, Luc et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 1, pp 115-122, issn 0041-1132, 8 p.Article

Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)VIGOUROUX, Stéphane; MICHALLET, Mauricette; CHEVALIER, Patrice et al.Haematologica (Roma). 2007, Vol 92, Num 5, pp 627-634, issn 0390-6078, 8 p.Article

Eosinophilic leukemia associated with t(2;5)(p23;q31)LEPRETRE, Stéphane; JARDIN, Fabrice; TILLY, Hervé et al.Cancer genetics and cytogenetics. 2002, Vol 133, Num 2, pp 164-167, issn 0165-4608Article

Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patientsSALLES, Gilles; MORSCHHAUSER, Franck; PISA, Pavel et al.Blood. 2012, Vol 119, Num 22, pp 5126-5132, issn 0006-4971, 7 p.Article

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'AdulteCOIFFIER, Bertrand; THIEBLEMONT, Catherine; BELHADJ, Karim et al.Blood. 2010, Vol 116, Num 12, pp 2040-2045, issn 0006-4971, 6 p.Article

Sμ mutation patterns suggest different progression pathways in follicular lymphoma : early direct or late from FL progenitor cellsRUMINY, Philippe; JARDIN, Fabrice; PICQUENOT, Jean-Michel et al.Blood. 2008, Vol 112, Num 5, pp 1951-1959, issn 0006-4971, 9 p.Article

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphomaREYES, Félix; LEPAGE, Eric; LAURENT, Guy et al.The New England journal of medicine. 2005, Vol 352, Num 12, pp 1197-1205, issn 0028-4793, 9 p.Article

Randomized comparison of double induction and timed-sequential induction to a 3 + 7 induction in adults with AML: Long-term analysis of the Acute Leukemia French Association (ALFA) 9000 studyCASTAIGNE, Sylvie; CHEVRET, Sylvie; JANVIER, Maud et al.Blood. 2004, Vol 104, Num 8, pp 2467-2474, issn 0006-4971, 8 p.Article

Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patientsBELHADJ, Karim; REYES, Félix; LEDERLIN, Pierre et al.Blood. 2003, Vol 102, Num 13, pp 4261-4269, issn 0006-4971, 9 p.Article

Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELADELFAU-LARUE, Marie-Hélène; DE LEVAL, Laurence; BRICE, Pauline et al.Haematologica (Roma). 2012, Vol 97, Num 10, pp 1594-1602, issn 0390-6078, 9 p.Article

Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA studyJARDIN, Fabrice; JAIS, Jean-Philippe; THIEBLEMONT, Catherine et al.Blood. 2010, Vol 116, Num 7, pp 1092-1104, issn 0006-4971, 13 p.Article

Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphomaD'AMORE, Francesco; RADFORD, John; HAGBERG, Hans et al.British journal of haematology. 2010, Vol 150, Num 5, pp 565-573, issn 0007-1048, 9 p.Article

Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis valueJARDIN, Fabrice; PICQUENOT, Jean-Michel; LEMASLE, Emilie et al.British journal of haematology. 2009, Vol 146, Num 6, pp 607-618, issn 0007-1048, 12 p.Article

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphomaTILLY, Hervé; LEPAGE, Eric; GISSELBRECHT, Christian et al.Blood. 2003, Vol 102, Num 13, pp 4284-4289, issn 0006-4971, 6 p.Article

Impact of the use of autologous stem cell transplantation at first relapse both in naïve and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 studyLE GOUILL, Steven; DE GUIBERT, Sophie; FRUCHART, Christophe et al.Haematologica (Roma). 2011, Vol 96, Num 8, pp 1128-1135, issn 0390-6078, 8 p.Article